NT-proBNP in Acute De Novo Heart Failure: A Key Biomarker for Predicting Myocardial Recovery—COMFE Registry
This study aims to analyze whether NT-proBNP at admission and discharge in de novo heart failure (HF) with reduced ejection fraction (HFrEF) is associated with myocardial recovery. This is a prospective observational study in two centers. Patients admitted with de novo HFrEF between 2021 and 2023 we...
Saved in:
| Main Authors: | Raquel López-Vilella, Inés Gómez-Otero, Víctor Donoso Trenado, David García-Vega, Óscar Otero-García, Luis Martínez Dolz, José Ramón González-Juanatey, Luis Almenar Bonet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/4/526 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Predicting Myocardial Recovery After Hospitalization for De Novo Heart Failure with Reduced Left Ventricular Ejection Fraction: Results from the COMFE Registry
by: Víctor Donoso-Trenado, et al.
Published: (2025-05-01) -
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01) -
NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01) -
Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01)